EP3313401
NANÓAGNIR SEM SAMANSTANDA AF SÍRÓLÍMUS OG ALBÚMÍNI TIL NOTKUNAR VIÐ MEÐFERÐ Á ÞEKJULÍKUM FRUMUÆXLUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2016EP published:
6.10.2021EP application number:
16818717.7
EP translation filed:
10.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
28.6.2036Expiry date:
28.6.2026Next due date:
30.6.2026
Title:
NANOPARTICLES COMPRISING SIROLIMUS AND AN ALBUMIN FOR USE IN TREATING EPITHELIOID CELL TUMORS
Timeline
Today
29.6.2016EP application
6.10.2021EP Publication
10.11.2021Translation submitted
15.12.2021Registration published
28.6.2026Expires
Owner
Name:
Abraxis BioScience, LLCAddress:
86 Morris Avenue, Summit, NJ 07901, US
Inventor
Name:
DESAI, Neil P.Address:
Pacific Palisades, CA 90272, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201562186252 PDate:
29.6.2015Country:
US
Classification
Categories:
A61K 31/436, A61K 38/38, A61K 47/42, A61K 9/00, A61K 9/08, A61K 9/10, A61K 9/19, A61K 9/14, A61K 9/51, A61P 35/00, A61P 35/04, G01N 33/574
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.5.2022
Expires: 28.6.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.5.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 7.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.